返回 Agenda
S15 : How ICH E17 Enables East Asian Countries to Change Their Development Strategies in Simultaneous Development?
Session Chair(s)
Hideharu Yamamoto, PhD
Biostatistics Deputy Dept Manage, Biometrics Dept
Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Nobushige Matsuoka, PhD
Pfizer R&D Japan G.K., Japan
Group Lead, Clinical Statistics Group 2, Biometrics & Data Management
Annie Xu
UCB China, China
China Biostatistician Lead,BQS East Asia
Kei Watabe
Sumitomo Pharma Co., Ltd., Japan
Senior Director, Biostatistics
Yasuto Otsubo
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of New Drug II
Guohua (James) Pan, PhD
Janssen China R&D Center, China
China Head of Statistics and Decision Sciences